Early body weight loss linked to shorter OS in gastric, gastroesophageal junction cancer

Body weight loss may predict poor outcomes among patients with metastatic gastric or gastroesophageal junction cancer receiving third-line or later treatment, according to study results presented at Gastrointestinal Cancers Symposium.“Nutritional status is closely linked to cancer mortality, and body weight loss has been shown to be prognostic for survival in curative, first- and second-line settings in metastatic gastric or gastroesophageal junction cancer,” Michele Ghidini, MD, PhD, researcher in the department of oncology at Azienda Ospedaliera di Cremona in Italy, andRead More